180 related articles for article (PubMed ID: 38101039)
21. Studies of small molecule interactions with protein phosphatases using biosensor technology.
Stenlund P; Frostell-Karlsson A; Karlsson OP
Anal Biochem; 2006 Jun; 353(2):217-25. PubMed ID: 16597430
[TBL] [Abstract][Full Text] [Related]
22. Roles and regulation of serine/threonine-specific protein phosphatases in the cell cycle.
Berndt N
Prog Cell Cycle Res; 2003; 5():497-510. PubMed ID: 14593745
[TBL] [Abstract][Full Text] [Related]
23. Activation of Aurora-A kinase by protein phosphatase inhibitor-2, a bifunctional signaling protein.
Satinover DL; Leach CA; Stukenberg PT; Brautigan DL
Proc Natl Acad Sci U S A; 2004 Jun; 101(23):8625-30. PubMed ID: 15173575
[TBL] [Abstract][Full Text] [Related]
24. Druggable cancer phosphatases.
Vainonen JP; Momeny M; Westermarck J
Sci Transl Med; 2021 Apr; 13(588):. PubMed ID: 33827975
[TBL] [Abstract][Full Text] [Related]
25. Role of tyrosine phosphatase inhibitors in cancer treatment with emphasis on SH2 domain-containing tyrosine phosphatases (SHPs).
Irandoust M; van den Berg TK; Kaspers GJ; Cloos J
Anticancer Agents Med Chem; 2009 Feb; 9(2):212-20. PubMed ID: 19199865
[TBL] [Abstract][Full Text] [Related]
26. Tapping the therapeutic potential of protein tyrosine phosphatase 4A with small molecule inhibitors.
Tasker NR; Rastelli EJ; Burnett JC; Sharlow ER; Lazo JS; Wipf P
Bioorg Med Chem Lett; 2019 Aug; 29(16):2008-2015. PubMed ID: 31307888
[TBL] [Abstract][Full Text] [Related]
27. The benzo[c]phenanthridine alkaloid, sanguinarine, is a selective, cell-active inhibitor of mitogen-activated protein kinase phosphatase-1.
Vogt A; Tamewitz A; Skoko J; Sikorski RP; Giuliano KA; Lazo JS
J Biol Chem; 2005 May; 280(19):19078-86. PubMed ID: 15753082
[TBL] [Abstract][Full Text] [Related]
28. Regulatory cascades of protein phosphatases: implications for cancer treatment.
Jailkhani N; Chaudhri VK; Rao KV
Anticancer Agents Med Chem; 2011 Jan; 11(1):64-77. PubMed ID: 21214508
[TBL] [Abstract][Full Text] [Related]
29. Protein phosphatases.
Barford D
Curr Opin Struct Biol; 1995 Dec; 5(6):728-34. PubMed ID: 8749359
[TBL] [Abstract][Full Text] [Related]
30. Targeting ERK1/2 protein-serine/threonine kinases in human cancers.
Roskoski R
Pharmacol Res; 2019 Apr; 142():151-168. PubMed ID: 30794926
[TBL] [Abstract][Full Text] [Related]
31. PROTACs, molecular glues and bifunctionals from bench to bedside: Unlocking the clinical potential of catalytic drugs.
Maneiro M; De Vita E; Conole D; Kounde CS; Zhang Q; Tate EW
Prog Med Chem; 2021; 60():67-190. PubMed ID: 34147206
[TBL] [Abstract][Full Text] [Related]
32. A Mg(2+)-dependent, Ca(2+)-inhibitable serine/threonine protein phosphatase from bovine brain.
Wang Y; Santini F; Qin K; Huang CY
J Biol Chem; 1995 Oct; 270(43):25607-12. PubMed ID: 7592734
[TBL] [Abstract][Full Text] [Related]
33. Double-edged roles of protein tyrosine phosphatase SHP2 in cancer and its inhibitors in clinical trials.
Song Y; Zhao M; Zhang H; Yu B
Pharmacol Ther; 2022 Feb; 230():107966. PubMed ID: 34403682
[TBL] [Abstract][Full Text] [Related]
34. Membrane protein phosphotyrosine phosphatase in rabbit kidney. Proteolysis activates the enzyme and generates soluble catalytic fragments.
Rotenberg SA; Brautigan DL
Biochem J; 1987 May; 243(3):747-54. PubMed ID: 2821989
[TBL] [Abstract][Full Text] [Related]
35. Phosphonate inhibitors of protein-tyrosine and serine/threonine phosphatases.
Kole HK; Smyth MS; Russ PL; Burke TR
Biochem J; 1995 Nov; 311 ( Pt 3)(Pt 3):1025-31. PubMed ID: 7487920
[TBL] [Abstract][Full Text] [Related]
36. Functional interrogation and therapeutic targeting of protein tyrosine phosphatases.
Krabill AD; Zhang ZY
Biochem Soc Trans; 2021 Aug; 49(4):1723-1734. PubMed ID: 34431504
[TBL] [Abstract][Full Text] [Related]
37. Sodium stibogluconate is a potent inhibitor of protein tyrosine phosphatases and augments cytokine responses in hemopoietic cell lines.
Pathak MK; Yi T
J Immunol; 2001 Sep; 167(6):3391-7. PubMed ID: 11544330
[TBL] [Abstract][Full Text] [Related]
38. Phosphatases as targets for cancer treatment.
Lazo JS; Wipf P
Curr Opin Investig Drugs; 2009 Dec; 10(12):1297-304. PubMed ID: 19943201
[TBL] [Abstract][Full Text] [Related]
39. Phosphatases as small-molecule targets: inhibiting the endogenous inhibitors of kinases.
Schmid AC; Woscholski R
Biochem Soc Trans; 2004 Apr; 32(Pt 2):348-9. PubMed ID: 15046606
[TBL] [Abstract][Full Text] [Related]
40. Using small molecules to target protein phosphatases.
Vintonyak VV; Waldmann H; Rauh D
Bioorg Med Chem; 2011 Apr; 19(7):2145-55. PubMed ID: 21420867
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
